Mosquirix (RTS,S) / GSK 
Welcome,         Profile    Billing    Logout  
 15 Diseases   4 Trials   4 Trials   891 News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mosquirix (RTS,S) / GSK
NCT06424002: The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children

Not yet recruiting
4
5400
NA
Mosquirixs, artemether-lumefantrine
Kamuzu University of Health Sciences, Ministry of Health, Malawi, Boston University, Michigan State University
Malaria,Falciparum
12/24
12/24
NCT03281291: Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.

Completed
2b
1500
RoW
GlaxoSmithKline
Malaria
04/22
10/23
EPI-MAL-003, NCT03855995: A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa

Recruiting
N/A
78000
RoW
Whole blood sample
GlaxoSmithKline
Malaria, Malaria Vaccines
05/25
05/25
RTSS/PBO, NCT04327440: RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in Malawi

Recruiting
N/A
3000
RoW
RTS,S/AS01 malaria vaccine, RTS,S, PBO bed nets
Michigan State University, University of Malawi College of Medicine, University of Maryland, College Park, Boston University, National Institute of Allergy and Infectious Diseases (NIAID)
Malaria, Malaria Vaccine, Insecticide-treated Bednets
03/23
03/24
MVPE-CC, NCT05041556: Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine

Recruiting
N/A
9280
RoW
Case-control study of clinical outcomes, Case-control study of mortality outcome
Kintampo Health Research Centre, Ghana, European Vaccine Initiative, London School of Hygiene and Tropical Medicine, African Research Collaboration for Health Limited, Kenya Medical Research Institute, University of Malawi, PATH
Malaria
04/25
04/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mosquirix (RTS,S) / GSK
NCT06424002: The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children

Not yet recruiting
4
5400
NA
Mosquirixs, artemether-lumefantrine
Kamuzu University of Health Sciences, Ministry of Health, Malawi, Boston University, Michigan State University
Malaria,Falciparum
12/24
12/24
NCT03281291: Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.

Completed
2b
1500
RoW
GlaxoSmithKline
Malaria
04/22
10/23
EPI-MAL-003, NCT03855995: A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa

Recruiting
N/A
78000
RoW
Whole blood sample
GlaxoSmithKline
Malaria, Malaria Vaccines
05/25
05/25
RTSS/PBO, NCT04327440: RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in Malawi

Recruiting
N/A
3000
RoW
RTS,S/AS01 malaria vaccine, RTS,S, PBO bed nets
Michigan State University, University of Malawi College of Medicine, University of Maryland, College Park, Boston University, National Institute of Allergy and Infectious Diseases (NIAID)
Malaria, Malaria Vaccine, Insecticide-treated Bednets
03/23
03/24
MVPE-CC, NCT05041556: Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine

Recruiting
N/A
9280
RoW
Case-control study of clinical outcomes, Case-control study of mortality outcome
Kintampo Health Research Centre, Ghana, European Vaccine Initiative, London School of Hygiene and Tropical Medicine, African Research Collaboration for Health Limited, Kenya Medical Research Institute, University of Malawi, PATH
Malaria
04/25
04/25

Download Options